12-2679450-G-C

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PP2PP3_ModerateBS2

The NM_000719.7(CACNA1C):​c.5098G>C​(p.Gly1700Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000449 in 1,560,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/19 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000049 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

12
2
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 9.30
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PP2
Missense variant in the CACNA1C gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 45 curated pathogenic missense variants (we use a threshold of 10). The gene has 91 curated benign missense variants. Gene score misZ: 6.4654 (above the threshold of 3.09). Trascript score misZ: 7.2674 (above the threshold of 3.09). GenCC associations: The gene is linked to intellectual disability, neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, Brugada syndrome, long QT syndrome, short QT syndrome, long qt syndrome 8, Timothy syndrome, Brugada syndrome 3.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.904
BS2
High AC in GnomAdExome4 at 69 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.5098G>C p.Gly1700Arg missense_variant Exon 42 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.5098G>C p.Gly1700Arg missense_variant Exon 42 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.5098G>C p.Gly1700Arg missense_variant Exon 42 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.5098G>C p.Gly1700Arg missense_variant Exon 42 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.5332G>C p.Gly1778Arg missense_variant Exon 44 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.5098G>C p.Gly1700Arg missense_variant Exon 42 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.5065G>C p.Gly1689Arg missense_variant Exon 41 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.5263G>C p.Gly1755Arg missense_variant Exon 43 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.5242G>C p.Gly1748Arg missense_variant Exon 44 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.5221G>C p.Gly1741Arg missense_variant Exon 42 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.5098G>C p.Gly1700Arg missense_variant Exon 42 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.5098G>C p.Gly1700Arg missense_variant Exon 42 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.5188G>C p.Gly1730Arg missense_variant Exon 42 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.5188G>C p.Gly1730Arg missense_variant Exon 42 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.5188G>C p.Gly1730Arg missense_variant Exon 42 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.5188G>C p.Gly1730Arg missense_variant Exon 42 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.5182G>C p.Gly1728Arg missense_variant Exon 43 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.5173G>C p.Gly1725Arg missense_variant Exon 43 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.5158G>C p.Gly1720Arg missense_variant Exon 43 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.5155G>C p.Gly1719Arg missense_variant Exon 42 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.5155G>C p.Gly1719Arg missense_variant Exon 42 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.5155G>C p.Gly1719Arg missense_variant Exon 42 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.5149G>C p.Gly1717Arg missense_variant Exon 42 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.5140G>C p.Gly1714Arg missense_variant Exon 42 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.5122G>C p.Gly1708Arg missense_variant Exon 41 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.5122G>C p.Gly1708Arg missense_variant Exon 41 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.5116G>C p.Gly1706Arg missense_variant Exon 41 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.5098G>C p.Gly1700Arg missense_variant Exon 42 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.5098G>C p.Gly1700Arg missense_variant Exon 42 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.5098G>C p.Gly1700Arg missense_variant Exon 42 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.5098G>C p.Gly1700Arg missense_variant Exon 42 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.5098G>C p.Gly1700Arg missense_variant Exon 42 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.5089G>C p.Gly1697Arg missense_variant Exon 42 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.5065G>C p.Gly1689Arg missense_variant Exon 41 of 46 ENSP00000507309.1 Q13936-19

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152176
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000490
AC:
69
AN:
1408374
Hom.:
0
Cov.:
31
AF XY:
0.0000418
AC XY:
29
AN XY:
694266
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000636
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152176
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74332
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Long qt syndrome 8 Uncertain:1
Oct 19, 2020
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as 3B-VUS. Following criteria are met: 0101 - Gain of function is a known mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant disease. (N) 0200 - Variant is predicted to result in a missense amino acid change from glycine to arginine (exon 42). (N) 0251 - Variant is heterozygous. (N) 0302 - Variant is present in gnomAD (v3) <0.001 for a dominant condition (1 heterozygote, 0 homozygotes). (P) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2) (12 heterozygotes, 0 homozygotes). (N) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools and highly conserved with a major amino acid change. (P) 0600 - Variant is located in an annotated domain or motif (CAC1F_C domain; PDB). (N) 0708 - Comparable variant has inconclusive previous evidence for pathogenicity. An alternate change to serine at the same residue has previously been described as a VUS in three patients with variable cardiac phenotypes (ClinVar, PMID: 31376648). (N) 0807 - Variant has not previously been reported in a clinical context. (N) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign -

not provided Uncertain:1
Aug 23, 2019
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Has not been previously published as pathogenic or benign to our knowledge; Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect -

Long QT syndrome Uncertain:1
Jun 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1700 of the CACNA1C protein (p.Gly1700Arg). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 1309437). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CACNA1C protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.55
D
BayesDel_noAF
Pathogenic
0.56
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.051
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.;T
Eigen
Pathogenic
0.73
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Pathogenic
0.83
D
MetaRNN
Pathogenic
0.90
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
0.89
D
MutationAssessor
Pathogenic
3.0
.;.;.;.;.;.;.;.;.;.;M;.;.;.;.;.;.;.;.;.;.;.;.
PrimateAI
Pathogenic
0.86
D
PROVEAN
Pathogenic
-6.9
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.
REVEL
Pathogenic
0.83
Sift
Uncertain
0.0030
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.
Sift4G
Benign
0.085
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;D;T;D;T
Polyphen
1.0, 0.90, 0.72, 0.99, 1.0
.;D;P;P;D;D;D;D;D;D;D;D;D;D;D;.;D;D;.;.;.;D;.
Vest4
0.88
MutPred
0.62
.;.;.;.;.;.;.;.;.;.;Gain of catalytic residue at N1753 (P = 0);.;.;.;.;.;.;.;.;.;.;.;.;
MVP
0.98
MPC
0.62
ClinPred
0.99
D
GERP RS
4.4
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs761966966; hg19: chr12-2788616; API